Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD)

Chatarina Löfqvist1, Gunnel Hellgren, Aimon Niklasson

  • 1Department of Ophthalmology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. chatarina.lofqvist@gu.se

Insights

Low insulin-like growth factor-1 (IGF-I) levels in the early weeks after birth are linked to the development of bronchopulmonary dysplasia (BPD) in very preterm infants. These findings highlight IGF-I as a potential biomarker for BPD risk.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Endocrinology

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant cause of morbidity in very preterm infants.
  • Insulin-like growth factor-1 (IGF-I) plays a crucial role in lung development and repair.
  • Understanding factors influencing BPD development is critical for improving infant outcomes.

Purpose of the Study:

  • To investigate the relationship between postnatal serum insulin-like growth factor-1 (IGF-I) levels and the development of bronchopulmonary dysplasia (BPD).
  • To identify early predictors of BPD in very preterm infants.

Main Methods:

  • A longitudinal study was conducted on 108 very preterm infants (mean gestational age 27.2 weeks).
  • Serum IGF-I levels were measured weekly from birth until 36 weeks postmenstrual age (PMA).
  • Multivariate regression models were used to determine independent predictors of BPD.

Main Results:

  • Infants who developed BPD had significantly lower mean serum IGF-I levels during postnatal days 3-21 and PMA 30-33 weeks compared to infants without BPD.
  • The rate of postnatal IGF-I increase was also lower in infants with BPD.
  • Lower gestational age, male gender, and lower mean serum IGF-I levels during the first three weeks were the strongest predictors of BPD.

Conclusions:

  • Lower serum IGF-I concentrations in the early postnatal period are associated with an increased risk of developing BPD in very preterm infants.
  • IGF-I may serve as an early biomarker for predicting BPD development.
  • These findings suggest potential therapeutic targets for preventing or mitigating BPD.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children from...